#ArnaPharma #SlateRunPharmaceuticals #Aridol #RespiratoryDiagnostics #SpecialtyPharma #DrugDevelopment #505b2 #Generics #PharmaNews #MedTech Arna Pharma Inc Slate Run Pharmaceuticals To view or add a comment, sign in Its always interesting to watch where large biopharma companies continue allocating long-term resources, especially in areas like cardiovascular and metabolic disease
Topical application through cream or serum can work for localized skin improvements, but absorption is limited, concentrations in commercial products are often insufficient, and youre not getting systemic effects that benefit hair follicles, internal wound healing, or broader tissue remodeling
Similarly, in an ongoing phase 3 trial in patients with Metabolic DysfunctionAssociated Steatohepatitis (MASH
[682] and ten Kulve et al
POH treatment reversed these hematological changes, except for the PLT level, indicating its protective effect on HPH rats by improving blood parameters and reducing blood viscosity